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Abstract
Ageing is the biggest risk factor for cardiovascular disease. Cellu-
lar senescence, a process driven in part by telomere shortening,
has been implicated in age-related tissue dysfunction. Here, we
address the question of how senescence is induced in rarely
dividing/post-mitotic cardiomyocytes and investigate whether
clearance of senescent cells attenuates age-related cardiac
dysfunction. During ageing, human and murine cardiomyocytes
acquire a senescent-like phenotype characterised by persistent
DNA damage at telomere regions that can be driven by mito-
chondrial dysfunction and crucially can occur independently of
cell division and telomere length. Length-independent telomere
damage in cardiomyocytes activates the classical senescence-
inducing pathways, p21CIP and p16INK4a, and results in a non-
canonical senescence-associated secretory phenotype, which is
pro-fibrotic and pro-hypertrophic. Pharmacological or genetic
clearance of senescent cells in mice alleviates detrimental
features of cardiac ageing, including myocardial hypertrophy
and fibrosis. Our data describe a mechanism by which senes-
cence can occur and contribute to age-related myocardial
dysfunction and in the wider setting to ageing in post-mitotic
tissues.
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Introduction
The role of cellular senescence in tissue maintenance, repair and
ageing is currently a rapidly evolving area of research under intense
focus. Cellular senescence is classically defined as an irreversible
loss of division potential of mitotic cells, often accompanied by a
senescence-associated secretory phenotype (SASP). While senes-
cence can be detrimental during the ageing process, it has also been
implicated in fundamental biological processes such as tumour
suppression, embryonic development and tissue repair (Mun˜oz-
Espı´n & Serrano, 2014).
Telomere shortening has been proposed as a major inducer of
senescence (Bodnar et al, 1998). Telomeres are repetitive sequences
of DNA, associated with a protein complex known as shelterin (de
Lange, 2005), which facilitates the formation of a lariat-like
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structure to shield the exposed end of DNA (Griffith et al, 1999),
thus protecting the ends of chromosomes from being recognised as
DNA damage (d’Adda di Fagagna et al, 2003). The current dogma
of telomere biology suggests that telomere shortening with each
successive cell division eventually disrupts the protective cap, lead-
ing to a sustained DNA damage response (DDR) and activation of the
senescence programme (Griffith et al, 1999). This hypothesis may
explain age-related degeneration of tissues maintained by constant
contribution of stem cell pools, such as the skin and hematopoietic
systems; however, it is insufficient to explain how senescence contri-
butes to ageing in primarily post-mitotic tissues such as the heart. As
such, the mechanisms that drive senescence in post-mitotic cells and
the contribution of post-mitotic cell senescence (PoMiCS) to tissue
degeneration during ageing are an emerging area of interest
(Anderson et al, 2018; Sapieha & Mallette, 2018).
Clinical heart failure (HF) represents a worldwide problem, and
over 50% of all patients exhibit HF with preserved ejection fraction
(HFpEF), which is a disease of the older population (Borlaug, 2014).
As the population continues to age, the prevalence of HFpEF is
increasing, currently at a rate of over 10% per decade (Borlaug &
Paulus, 2011). During ageing, the heart undergoes distinct physio-
logical and molecular changes, including cardiomyocyte (CM)
hypertrophy and increased fibrosis, which contribute to increased
ventricular stiffness causing a reduction in diastolic but not systolic
cardiac function (Strait & Lakatta, 2012). Despite the growing need
for interventions, effective treatments for HFpEF have yet to be
identified (Borlaug & Paulus, 2011).
Critically short telomeres, induced by breeding of multiple gener-
ations of mice lacking the catalytic subunit of telomerase Terc, lead
to cardiac dysfunction and myocardial remodelling (Wong et al,
2008). However, replicative senescence-induced telomere shorten-
ing is unlikely to reflect normal physiological myocardial ageing,
considering that the majority of CMs are post-mitotic, withdrawing
from the cell cycle shortly after birth. While the heart has a limited
potential for regeneration, CM turnover rates in both humans and
mice are extremely low (Senyo et al, 2013; Bergmann et al, 2015;
Richardson et al, 2015). We and others have reported that stress-
induced telomere damage can also lead to telomere dysfunction and
induce senescence (Fumagalli et al, 2012; Hewitt et al, 2012).
Therefore, we investigated whether this phenomenon occurs in CMs
and whether CM senescence contributes to myocardial remodelling
during ageing.
Here, we demonstrate for the first time that a CM senescence-like
phenotype is a feature of normal physiological human and murine
ageing and provide a novel mechanistic model by which senescence
occurs in rarely dividing/post-mitotic tissues. Persistent DNA
damage foci, which co-localise with telomere regions, increase in
cardiomyocytes with age independently of telomere length, telom-
erase activity or DNA replication and can be induced by mitochon-
drial dysfunction in vitro and in vivo. Global gene expression
analysis of purified CMs, isolated from young and old mice, indi-
cates activation of the classical senescence growth arrest pathways
and of a distinct non-canonical SASP with functional effects includ-
ing the potential to promote myofibroblast differentiation in fibro-
blasts and CM hypertrophy. Furthermore, specific induction of
length-independent telomere dysfunction in CMs induces several
senescence markers, including hypertrophy, which importantly is
also associated with CM senescence in vivo. Finally, we demonstrate
that suicide gene-mediated ablation of p16Ink4a-expressing senescent
cells and treatment with the senolytic drug, navitoclax, reduces CMs
containing dysfunctional telomeres and attenuates cardiac hyper-
trophy and fibrosis in aged mice.
Results
Length-independent telomere damage in aged
cardiomyocytes in vivo
Previously, we defined a novel mechanism of cellular senescence
via the induction of irreparable telomere damage that occurs in the
absence of telomere shortening (Hewitt et al, 2012). These data led
us to hypothesise that this form of telomere damage could be the
process by which senescence occurs in post-mitotic, or rarely divid-
ing cells, which are not subject to proliferation-associated telomere
shortening. We therefore investigated telomere dysfunction in adult
mice throughout ageing by using dual Immuno-FISH to quantify co-
localisation between DDR proteins cH2A.X, 53BP1 and telomeres,
hereafter referred to as telomere-associated foci (TAF) in CMs
(Fig 1A). CMs were identified by CM-specific markers a-actinin,
troponin-C and the perinuclear protein PCM1 (Richardson, 2016;
Richardson et al, 2015; Fig EV1A–C).
Mean TAF per CM and the total % of CMs containing TAF
increased significantly with age in both mouse and human hearts
(Figs 1A–C and EV1A). In contrast, the total number of cH2A.X foci
did not change with age and were detected in almost all adult CMs
irrespective of age (Fig 1D and E). Similar results were obtained
when analysing co-localisation between DDR protein 53BP1 and
telomeres in young and old mice (Fig EV1B). Interestingly, CMs from
old animals contained a significantly higher number of TAF than
other cardiac cell types (Fig EV1C), suggesting that telomere dysfunc-
tion is a predominant feature of CM ageing. To confirm further the
localisation of a DDR at telomeres, we performed chromatin immuno-
precipitation (ChIP) on cross-linked chromatin from heart tissue,
using an antibody against cH2A.X followed by quantitative real-time
PCR for telomeric repeats. We found enrichment of cH2A.X at telom-
eres in 30-month-old mice compared to 3-month-old mice (Fig 1F).
Although the majority of the adult CMs are considered post-
mitotic, the adult heart retains limited potential for CM proliferation
(Senyo et al, 2013; Bergmann et al, 2015; Richardson et al, 2015). We
next investigated whether increased TAF was the outcome of telomere
shortening driven by replication and/or impaired telomerase activity.
Having first observed that telomerase activity was not affected by
mouse age (Fig 1G), we observed a significant reduction in telomere
FISH signal when comparing 4- to 30-month-old mice (Fig 1H).
However, the median telomere FISH signal detected in old wild-type
(30 months) mice was comparatively higher than that found in
fourth-generation Terc/ (G4) where critical telomere shortening has
been shown to induce cardiac dysfunction (Wong et al, 2008; Fig 1I).
3D super-resolution stimulated emission depletion microscopy
(STED) was used to more accurately detect telomere length by Q-
FISH in CMs. STED resolution is typically 50 nm in XY and 150 nm
in Z and overcomes the so-called diffraction limit of conventional
confocal microscopy, which yields resolutions of ≥ 200 nm. Using
STED, we could identify an increased number of telomeres detected
per CM, as well as decreased individual telomere volume when
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compared to conventional confocal microscopy (Fig EV1D and E, and
Movie EV1). STED microscopy also revealed the existence of clusters
of telomeres with varying lengths, which would otherwise be identi-
fied as single telomere signals by confocal microscopy (Fig EV1D).
We then proceeded to analyse telomere FISH intensities in telom-
eres co-localising with cH2A.X (TAF) and those not co-localising
with cH2A.X (non-TAF) in aged mice using STED and found no
significant differences (Fig EV1F and G). Similar observations were
made in CMs from aged human hearts (Fig EV1H). Analysis of
telomere FISH intensities by STED in individual cardiomyocytes
revealed that telomeres with low FISH intensity co-localising with
cH2A.X are relatively rare (Fig EV1I). Together, our data suggest
that length-independent telomere-associated DNA damage is unli-
kely to be due to the limitations of conventional confocal micro-
scopy and that the shortest telomeres are not preferentially
signalling a DDR.
While CM proliferation is negligible in adult humans and mice, it
is possible that TAF may be the outcome of a small fraction of
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Figure 1. Telomere dysfunction increases with age in mouse cardiomyocytes.
A Representative images of cH2AX immuno-FISH in troponin-C-positive/a-actinin-positive (top left and bottom left panels, respectively) mouse CMs (white—
troponin-C/a-actinin; red—telo-FISH; green—cH2AX). Images are Z-projections of 0.1 lm stacks taken with a 100× oil objective. Scale bar: 20 lm. Right panels
represent a single z-planes where co-localisation between a cH2AX foci and telomere was observed. Scale bars 1 lm. (Below) 3D reconstruction of Immuno-FISH
using STED microscopy for cH2A.X and telomeres in a CM from 30-month-old mice. Scale bars as indicated and scale the same for both individual TAF examples
using STED.
B, C Mean number of TAF (B) and % of TAF-positive (C) a-actinin-positive CMs from C57BL/6 mice. Data are mean  SEM of n = 4–7 mice per age group. 100 a-actinin-
positive CMs were quantified per mouse.
D, E Mean number of total cH2A.X foci (D) and % of cH2A.X foci-positive nuclei (E) in a-actinin-positive CMs from C57BL/6 mice. Data are mean  SEM of n = 4–7 mice
per age group. 100 a-actinin-positive CMs were quantified per mouse.
F Fold enrichment of cH2AX at telomere repeats by real-time PCR. Graph represents fold enrichment of cH2AX at telomeric repeats between IgG control, 3- and 30-
month-old whole mouse hearts. Data are mean  SEM of n = 3 mice per age group.
G Quantitative PCR-ELISA TRAP assay comparing telomerase activity of 3- and 30-month-old C57BL/6 mice whole heart lysates. Data are mean  SEM of n = 4 mice
per age group.
H Histograms displaying distributions of telomere intensity in CMs analysed by 3D Q-FISH in young (4 months) and old (30 months) wild-type mice. Data are from
n = 3 mice. > 100 CMs were analysed per mouse.
I % of telomere FISH signal loss in 30-month-old wild-type mice and late generation Terc/ mice (6 months old) in comparison with 4-month-old wild-type mice.
Data are from n = 3 mice. > 100 CMs were analysed per mouse.
Data information: Statistical analysis was performed using one-way ANOVA (Holm–Sidak method) for multiple comparisons and Mann–Whitney test and two-tailed t-
test for single comparisons. ***P < 0.001; **P < 0.01.
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dividing CMs. To ascertain further whether age-associated accumu-
lation of TAF can occur in post-mitotic cells and is not exclusively
linked to CM proliferation and turnover during ageing, we analysed
our data in a mathematical model of a CM population over
27 months of a mouse lifespan. Our simulations reveal that, even
considering relatively high estimates of cell division rates (4–15%),
CM proliferation cannot account for the rate of the age-dependent
increase in TAF. Rather, if we assume that proliferation plays no
role in the TAF increase with age and that TAF are generated in
non-dividing cells, there is a high degree of correlation between the
model and our experimental data (Appendix Fig S1). In the mdx4cv/
mTRG2 mouse model of telomere dysfunction, reduced expression of
shelterin components is suggested to underlie increased telomere
erosion in CMs (Mourkioti et al, 2013; Chang et al, 2016). To test
whether uncapping of telomeres contributes to induction of a DDR
at telomeres during ageing, we quantified the expression of shelterin
components in CMs isolated from young and old wild-type mice and
found no significant differences (Appendix Fig S2A). Similarly, we
observed no significant difference in the abundance of TRF2 (an
essential component of t-loop formation) in either TAF or non-TAF
in human CMs in vivo (Appendix Fig S2B).
Together, these data support the notion that TAF increase with
age in CMs and this occurs as a result of a process that is indepen-
dent of cell proliferation can occur independently of telomere short-
ening and is not a result of overt alteration of telomere regulatory
factors, such as shelterin components and telomerase. Having
shown the phenomenon of telomere dysfunction occurring in CMs
in vivo, we also found an age-dependent increase in TAF (but not
non-TAF) in other post-mitotic cells, specifically in skeletal muscle
myocytes and hippocampal neurons, which indicates the wide-
spread nature of this phenomenon (Appendix Fig S3A–G).
Telomere damage is persistent in cardiomyocytes
Work by us and others previously demonstrated demonstrated that
stress exposure leads to activation of a persistent DDR at telomeric
regions (Fumagalli et al, 2012; Hewitt et al, 2012). To investigate
the kinetics and nature of the DDR in CMs, we utilised different
in vitro models. We first observed that exposure to X-ray radiation
(10 Gy) resulted in both telomere-associated foci (TAF) and non-
telomere-associated DNA damage foci (non-TAF) in mouse embry-
onic CMs positive for troponin-C and PCM1 (Fig 2A). However, only
TAF were persistent, with non-TAF numbers being significantly
reduced with time (Fig 2B).
Cultures of rat neonatal CMs and the myoblast cell line (H9C2)
treated with stressors H2O2 and X-ray irradiation, respectively,
showed that the number of TAF remained persistent over time
(Fig 2C and D). Three days subsequently to X-ray irradiation, we
monitored DDR in H9C2 cells using a 53BP1-GFP fusion protein
(Passos et al, 2010) and time-lapse microscopy (Fig 2E). Over a 10-
h time-course, the majority of individual DDR foci could be seen to
be rapidly resolved with only approximately 20% of the original
DNA damage foci persisting throughout the time-course (Fig 2F),
similar to the % of TAF-positive cells for this time point (Fig 2D).
To determine whether persistent TAF can also be induced in adult
CMs in vivo, we exposed young mice to a whole-body dose of 2 Gy
X-ray irradiation and measured the level of TAF in CMs after 11-
month recovery. Both the mean number of TAF and % of CMs posi-
tive for TAF were significantly higher (Fig 2G). Altogether, these
data suggest that the majority of genomic DNA damage in CMs is
reparable and that only telomeric DNA damage is irreparable and
persistent.
Double-strand breaks can arise in telomeres due to replication
errors when replication forks encounter single-stranded breaks. In
order to ascertain whether TAF could be induced in the absence of
cell division, we pre-incubated H9C2 cells with EdU for 3 h and
subjected them to either X-ray irradiation (10 Gy) or 10 lM H2O2.
Following a 24-h recovery period (in the presence of EdU), the mean
number of TAF was significantly increased in cells, which did not
incorporate EdU (Appendix Fig S4A), indicating that TAF can be
induced in the absence of DNA replication. Further, we isolated
adult mouse CMs, which do not proliferate in culture, and exposed
▸Figure 2. Stress-induced telomere-associated DNA damage is persistent in mouse embryonic cardiomyocytes, rat neonatal cardiomyocytes and H9C2myoblasts.
A Representative images of mouse embryonic cardiomyocytes at days 0, 3, 5 and 10 days following 10 Gy X-irradiation. Left panels represent troponin-C-positive
embryonic cardiomyocytes (troponin-C—magenta; DAPI—light blue). Middle panels display cH2AX foci (green) and telomeres (red) in Z-projections of 0.1 lm slices,
with white arrows indicating co-localisation. Co-localising foci are amplified in the right-hand panels (amplified images represent a single z-planes where co-
localisation was observed). Scale bars represent 10 lm. Scale bars in single-plane images 500 nm.
B (Left) Mean number of both TAF and non-TAF in troponin I-positive mouse embryonic cardiomyocytes at days 0, 3, 5 and 10 following 10 Gy X-irradiation. Data are
mean  SEM of n = 3 independent experiments; 30–50 troponin-positive cardiomyocytes were analysed per experiment. (Right) Mean percentage of cH2AX foci co-
localising with telomeres (% TAF) in troponin-C-positive mouse embryonic cardiomyocytes at days 0, 3, 5 and 10 following 10 Gy X-irradiation. Statistical analysis
performed using one-way ANOVA (Holm–Sidak method); *P < 0.05. Significant differences were found for mean number of non-TAF, but not for mean number of TAF.
C Mean number of both TAF and non-TAF in neonatal rat cardiomyocytes at days 0, 3, 5, 10 days following treatment for 24 h with H2O2. Data are mean  SEM of
n = 3. > 50 cells were quantified per condition. Statistical analysis performed using one-way ANOVA (Holm–Sidak method); **P < 0.01.
D (Left) Representative images of cH2AX immuno-FISH in H9C2 myoblasts 3 days 10 Gy X-irradiation (red—telo-FISH; green—cH2AX). White arrows identify areas
shown in higher magnification panels. (Right) Mean number of both TAF and non-TAF in H9C2 myoblasts at days 3 and 5 following 10 Gy X-irradiation. Data are
mean  SEM of n = 3. > 50 cells were quantified per condition. Statistical analysis performed using one-way ANOVA (Holm–Sidak method); ***P < 0.001. Scale bars
represent 1 lm. Scale bars in single-plane images 500 nm.
E Representative time-lapse images of H9C2 rat cardiomyoblasts expressing AcGFP-53BP1 from 3 days after 10 Gy irradiation at the indicated times (min). Images are
maximum intensity projections with a 6.7 lm focal depth. Scale bar represents 1 lm.
F Kaplan–Meier survival curves for AcGFP-53BP1c DDR foci in H9C2 cells 3 days after 10 Gy irradiation at 10-min intervals for 24 h. > 500 foci from 10 cells were
tracked per condition. Gehan–Breslow test was used, P < 0.001.
G Schematic illustration showing 1-month-old C57BL/6 mice treated with 2 Gy whole-body X-irradiation, followed by a recovery period of 11 months before culling at
12 months of age. Mean number of TAF in a-actinin-positive cardiomyocytes. Data are mean  SEM of n = 3 mice per group. Ninety a-actinin-positive
cardiomyocytes were quantified per condition. Statistical analysis performed using two-tailed t-test; *P < 0.05.
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them to 5 lM H2O2. We observed that the mean number of TAF
was significantly increased after treatment (Appendix Fig S4B). In
addition, we did not find evidence that the shortest telomeres were
specifically targeted by stressors. In fact, EdU-negative irradiated
H9C2 cells had a slightly higher median telomere length in damaged
telomeres (TAF) compared to telomeres that did not co-localise with
cH2A.X (non-TAF). However, such a difference was not found in
adult murine CMs treated with H2O2 (Appendix Fig S4C).
Telomere-specific DNA damage drives a senescent-like
phenotype
Having demonstrated that TAF increase with age and can be
induced due to stress, we then tested whether telomere-specific
damage could directly drive a senescent-like phenotype in the CM
lineage. Rat neonatal CMs were transfected with an endonuclease
that specially targets telomeres [a TRF1-FokI fusion protein and a
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TRF1-Fok1D450 inactive mutant (Dilley et al, 2016)]. In culture,
we found that rat neonatal CMs had very low proliferation rates
with 5% of cells incorporating EdU over a period of 24 h. Follow-
ing 5 days of culture, CMs expressing TRF1-FokI showed numerous
DNA damage foci with the significant majority of damage co-loca-
lising with telomeres (Fig 3A–C). Telomeres were targeted by the
endonuclease irrespectively of their length (Fig 3D). De novo TAF
formation induced a senescent phenotype in CMs characterised, in
addition to TAF, by increased SA-b-Gal activity and upregulation of
the cyclin-dependent kinase inhibitor p21CIP (Fig 3E and F), as well
as increased cellular hypertrophy (Fig 3G). Similar results were
found using the H9C2 myoblasts (Fig EV2A–E). Additionally, we
used the AC10 cell line derived from adult human ventricular CM
(Davidson et al, 2005) stably expressing an inducible form of the
TRF1-FokI construct. These cells express CM-specific transcription
factors and contractile proteins and, while proliferative in complete
media, are induced to terminal differentiation and exit the cell cycle
under mitogen-depleted conditions. We induced TRF1-FokI expres-
sion in differentiated AC10 cells by exposure to doxycycline (DOX)
for 6 h and allowed the cells to recover for an additional 36 h in
the absence of DOX. Consistent with the idea that telomere damage
is irreparable in differentiated CMs, we found that expression of
TRF1-FokI significantly increased the mean number of TAF and this
number persisted for at least 36 h (Fig EV2F and G). Additionally,
expression of TRF1-FokI resulted in increased SA-b-Gal activity
(Fig EV2H). In contrast, if similar numbers of non-telomeric DNA
damage foci were induced using the homing endonuclease I-PpoI in
neonatal cardiomyocytes, we observed that most DNA damage is
repaired within 4 days, without induction of senescent markers or
increased cell size (Fig EV2I–K).
Aged cardiomyocytes activate senescence pathways but not a
typical SASP
Within the heart, CMs comprise approximately only 30% of the
total cells (Nag & Zak, 1979). To overcome this heterogeneity and
obtain an accurate representation of the CM transcriptome during
ageing, we devised a new method for isolation and enrichment of
CMs. In short, we conducted a retrograde Langendorff perfusion
for dissociation of cardiomyocytes, followed by removal of
CD31+/CD45+/ScaI+ interstitial cells via magnetic bead sorting
(Fig 4A). This method allowed us to obtain a highly enriched
cardiomyocyte population (Fig EV3A). RT–PCR quantification of
mRNAs encoding the cyclin-dependent kinase inhibitors p16Ink4a,
p21CIP and p15Ink4b in 3- and 20-month-old animals demonstrated
an age-dependent increase in expression of all three genes
(Fig 4B). Immunohistochemistry on tissue sections from ageing
mice validated the increase of p21CIP at the protein level, specifi-
cally in CMs (Fig 4C). Furthermore, we detected increased activity
of SA-b-Gal in old mice (Fig 4D). While SA-b-Gal positivity was
rare, we could detect it in CMs but no other cell types from old
mice. By centromere-FISH in CMs, we also observed an age-depen-
dent increase of senescence-associated distension of satellites
(SADS), a marker of senescence (Swanson et al, 2013; Fig 4E).
Global transcription analysis of purified CM populations by RNA-
sequencing revealed 416 differentially expressed genes between
young (3 months) and old (20 months; Fig EV3B) mice. Principal
component analysis revealed that both cohorts separate well with
the first and second components, accounting for 80.1 and 7.8% of
the cumulative variance across the data set (Fig EV3C). Consistent
with rare CM proliferation in vivo, we did not observe any signifi-
cant changes in the expression of proliferation genes (Fig EV3D).
However, genes involved in the regulation of myofilaments,
contraction and CM hypertrophy were enriched in old mice
(Myh7, Capn3, Ankrd1, Myom3, Myot, Mybpc2). Confirmatory
qRT–PCR showed age-dependent increase in hypertrophy genes
Myh7 and Acta1, but not Anf (Fig EV3E and F). Interestingly, pro-
inflammatory genes associated with the SASP (Coppe´ et al, 2008),
such as Il-1a, Il-1b, Il-6, Cxcl1 and Cxcl2, were not differentially
expressed between CMs from young and aged animals (Fig 4F).
To determine whether SASP factors were secreted by CMs, we
collected conditioned medium from isolated CMs from young and
old mice. In accordance with the RNA-seq results, we did not find
any significant differences in the levels of secreted proteins using
a cytokine array (Fig 4F).
Our data are in contrast with a previous report that shows
increased expression of SASP components in murine heart with age
using whole heart homogenates (Ock et al, 2016). We therefore
compared the expression of previously reported SASP components
in non-purified and purified CM populations. Consistently, we found
that following a simple Langendorff digestion that collects a hetero-
geneous population of CMs and stromal cells, we found significant
differences in expression of SASP components such as Il-6 and Cxcl1
between young and old mice (Appendix Fig S5A). However, the
population of purified CMs demonstrated no such differences,
suggesting that cell types other than CMs could explain previous
observations (Appendix Fig S5A). Interestingly, RNA sequencing led
to the identification of three secreted proteins, not commonly cate-
gorised as SASP components, which were confirmed to be signifi-
cantly increased at the mRNA level in aged purified CMs: Edn3,
Tgfb2 and Gdf15 (Fig 5A). Of these, only Edn3 was increased exclu-
sively in aged CMs, but neither in cardiac stromal cells nor in other
organs, suggesting that increased Edn3 levels in plasma is a good
indicator of CM ageing (Appendix Fig S5B–D). The SASP has been
shown to impact on proliferation of neighbouring cells, ultimately
inducing senescence (Acosta et al, 2013). Consistently, we found
that conditioned medium isolated from old adult CMs reduced
proliferation of neonatal fibroblasts (measured by EdU incorpora-
tion) and increased the expression of a-smooth muscle actin (a-
SMA), an indicator of myofibroblast activation (Fig 5B–E). We
then examined in more detail the role of the newly identified CM
senescence-associated proteins in terms of their ability to induce
bystander effects, particularly their role in fibrosis, proliferation
and hypertrophy. We found that Edn3, Tgfb2 and Gdf15 induced
expression of a-SMA in fibroblasts; however, only Tgfb2 reduced
cellular proliferation as measured by EdU incorporation (Fig 5F–
H). Furthermore, treatment of neonatal rat CMs with Edn3 or
Tgfb2, but not Gdf15, resulted in a significant increase in the cell
surface area, supporting their involvement in the induction of
hypertrophy (Fig 5I). Consistent with previous reports indicating
that the SASP can induce senescence in neighbouring cells
(Acosta et al, 2013), we found that conditioned medium from old
adult CMs was able to induce an increase in SA-b-Gal and a
reduction in EdU incorporation in fibroblasts. No significant
increase in DNA damage foci was observed in fibroblasts
(Appendix Fig S5E–H).
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Figure 3. TRF1-FokI fusion protein induces telomere-specific double-strand breaks, senescence and hypertrophy in rat neonatal cardiomyocytes.
A Representative images of rat neonatal CMs 4 days following transfection with a FLAG-tagged TRF1-FokI-D450A (top row) or TRF1-FokI (middle and bottom row)
fusion protein (cell treatments the same for all subsequent panels in Figure; red—telo-FISH; green—cH2A.X). Images are z-projections of 0.1 lm stacks taken with
100× objective. White arrows indicate co-localisation between telomeres and cH2A.X, with co-localising foci amplified in the right panels (taken from single z-
planes where co-localisation was found). Scale bar represents 3.5 lm. Scale bar in magnified images showing individual co-localisation 500 nm.
B, C % of cH2A.X foci co-localising with telomeres (B) and mean number of telomere-associated foci (TAF) (C) in FLAG-tagged TRF1-FokI-D450A- and TRF1-FokI-
expressing CMs. Data are mean  SEM of n = 4 independent experiments. > 50 cells were analysed per condition. Statistical analysis was performed by two-tailed
t-test ***P < 0.001.
D Histograms displaying telomere intensity for telomeres co-localising or not co-localising with cH2AX foci. Red dotted lines represent median. Mann–Whitney test
shows no significant difference in telomere intensity between TAF and non-TAF.
E Mean % of FLAG-labelled CMs positive for SA-b-Gal activity. Data are mean  SEM of n = 3 independent experiments. > 100 cells were quantified per condition.
Statistical analysis performed using two-tailed t-test; **P < 0.01.
F Expression of p21 mRNA (as a function of b-actin and Gapdh) by real-time PCR in TRF1-FokI-D450A and TRF1-FokI-expressing CMs. Data are mean  SEM of n = 6
independent experiments. Statistical analysis performed using two-tailed t-test; ***P < 0.001.
G Mean  SEM cell surface area (lm2) of FLAG-labelled CMs expressing TRF1-FokI-D450A and TRF1-FokI. Statistical analysis performed using two-tailed t-test;
***P < 0.001. Scale bar represents 50 lm.
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A Scheme illustrating CM isolation and purification procedure.
B Real-time PCR gene expression analysis in isolated mouse CMs from C57BL/6 mice. Data are mean  SEM of n = 3–4 per age group. Statistical analysis performed by
one-way ANOVA (Holm–Sidak method); *P < 0.05.
C Mean % of p21-positive CM nuclei from 3-, 15- and 30-month-old C57BL/6 mice by immunohistochemistry (IHC). Data are mean  SEM of n = 4 per age group.
> 100 CMs were quantified per age group. Statistical analysis performed using one-way ANOVA (Holm–Sidak method); *P < 0.05.
D Mean % of 3- and 24-month-old mouse CMs staining positive for SA-b-Gal in vivo with representative images above (blue—SA-b-Gal; green—troponin-C; red—WGA).
Black arrows indicate SA-b-Gal expression in a troponin-C-expressing CM. Statistical analysis performed using two-tailed t-test; *P < 0.05. Data are mean  SEM
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E Mean % of SADS-positive CM nuclei from 3- and 30-month-old mouse CMs positive for SADS in vivo, as detected by centromere-FISH. Data are mean  SEM of n = 4
per age group. > 200 CMs per mouse were quantified. Statistical analysis performed using two-tailed t-test; *P < 0.05.
F SASP heatmap: Pearson correlation clustered heatmap showing a curated list of known SASP genes (top panel) or a selection of secreted SASP proteins (bottom panel)
in young (3 months) and old (20 months) mouse CMs (n = 5 per age group). The colour intensity represents column Z-score, where red indicates highly and blue
lowly expressed.
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We conclude that aged CMs in vivo activate a number of senes-
cence effector pathways, including hypertrophy and a non-typical
SASP, which may mediate both autocrine and paracrine effects.
Mitochondrial ROS drive TAF in mouse cardiomyocytes in vivo
Mitochondrial dysfunction has been described as both a driver and
consequence of cellular senescence (Passos et al, 2007, 2010;
Correia-Melo et al, 2016). Gene Set Enrichment Analysis (GSEA) of
RNA-seq data revealed that the most negatively enriched Gene
ontology term in old CMs is the mitochondrial inner membrane
(Fig EV4A). Consistently, in CMs from old mice we observed an
overall decline in expression of most mitochondrial genes, particu-
larly those genes involved in the electron transport chain (ETC;
Fig 6A) and mitochondrial ultrastructural defects by transmission
electron microscopy (Fig EV4B).
We then speculated whether mitochondrial ROS could be a driver
of telomere dysfunction in CMs in vivo. Previous data indicate that
mitochondrial ROS can drive telomere shortening in vitro (Passos
et al, 2007) and that telomere regions are particularly sensitive to
oxidative damage (Hewitt et al, 2012). Consistent with this hypothe-
sis, we found increased mRNA expression of the pro-oxidant
enzyme monoamine oxidase A (MAO-A) and decreased expression
of antioxidant enzymes mitochondrial MnSOD and catalase in
isolated CMs from old mice (Fig 6B). Furthermore, we found
increased lipid peroxidation marker, 4-HNE, and DNA oxidation
marker, 8-oxodG, in hearts with age (Fig 6C). To address whether
these age-associated changes are causal in TAF induction, we
utilised a model of CM-specific overexpression of MAO-A (MHC-
MAO-A tg), which displayed enhanced levels of mitochondrial ROS
specifically in CMs (Villeneuve et al, 2013). In this transgenic
mouse, both the mean number and % of CMs positive for TAF were
significantly increased compared to age-matched controls (Fig 6D).
Critically, when transgenic animals were treated with the antioxi-
dant N-acetyl cysteine (NAC), both the increase in TAF (Fig 6D)
and CM hypertrophy were significantly rescued (Fig EV4C).
Complementary studies in old MnSOD+/ and Catalase/ mice
also revealed that these had a higher number of TAF than age-
matched controls (Fig 6E and F). Furthermore, we found a signifi-
cant increase in TAF in CMs from Polgmut/mut mice, a model of
accelerated ageing due to mitochondrial dysfunction (Trifunovic
et al, 2004; Fig 6G). Increased telomere dysfunction in these mice
was associated with decreased expression of mitochondrial proteins,
increased expression of p21, and cardiac hypertrophy (Fig EV4D).
Finally, treatment of isolated adult CMs with rotenone, a mitochon-
drial complex I inhibitor, induced TAF, which could be rescued by
treatment with the antioxidant NAC (Fig 6H).
In summary, CMs from aged heart exhibit downregulation of
mitochondrial inner membrane and ETC. genes, and this is associ-
ated with indicators of increased ROS metabolism that is causative
of telomere-associated DNA damage.
Senescent-cell clearance reduces cardiac hypertrophy
and fibrosis
Myocardial remodelling occurs with ageing. Furthermore, it accom-
panies diseases such as ischaemia, hypertension, valvular disease
and heart failure. In order to assay cardiac function with ageing in
mice, we used magnetic resonance imaging (MRI). We found no
significant difference in systolic cardiac function (ejection fraction)
with age. However, we observed an increased mean left ventricle
mass (mean of diastolic and systolic mass) indicative of hypertrophy
and increased ventricle wall rigidity, symptomatic of a decline in
diastolic function, both of which are characteristics of HFpEF
patients (Borlaug, 2014) and aged mice (Dai et al, 2012; Fig 7A).
Previously, we showed that specific induction of TAF was
associated with increased cell size in rat neonatal CMs in vitro
and that CM senescence is associated with hypertrophy in vivo.
Consistent with a role for TAF-induced senescence in age-depen-
dent cardiac hypertrophy, we found that larger CMs from old
mice had generally higher TAF frequencies (Fig 7B). In order to
determine whether there is a causal relationship between senes-
cence and cardiac hypertrophy, we used the INK-ATTAC mouse
model, in which a small molecule, AP20187 (AP), induces apopto-
sis through dimerisation of FKBP-fused Casp8. Using this model,
it has previously been shown that clearance of p16-expressing
cells improves multiple parameters of physical health and function
within ageing mice (Baker et al, 2011, 2016; Farr et al, 2017;
Ogrodnik et al, 2017).
In order to establish if elimination of p16Ink4a-positive cells
reduced TAF in CMs, we aged INK-ATTAC mice until they were
27 months old and treated them with AP for 2 months (Fig 7C). We
confirmed by RNA in situ hybridisation that both p16Ink4a- and
eGFP-positive cells were significantly reduced in hearts following
▸Figure 5. Cardiomyocyte SASP induces fibrosis and reduces proliferation in fibroblasts and induces hypertrophy in cardiomyocytes.A (Above) RNA sequencing of purified CMs from four mice per age group reveals age-dependent increased expression of three secreted proteins Edn3, Tgfb2 and
Gdf15; the colour intensity represents column Z-score, where red indicates highly and blue lowly expressed. (Below) mRNA expression of Edn3, Tgfb2 and Gdf15 was
independently validated by RT–PCR in young and old isolated adult CMs. Data are mean  SEM of n = 5 mice per group.
B CMs were isolated by Langendorff heart perfusion, purified and cultured for 48 h. Conditioned medium (CM) was collected and added to cultures of neonatal
fibroblasts in the presence of 10 lM EdU.
C Representative images of immunofluorescent staining against a-SMA and EdU in neonatal fibroblasts cultured in the presence of CM from young and old CMs.
D, E Quantification of % of EdU incorporation (D) and % of a-SMA-positive cells (E) in neonatal fibroblasts after treatment for 48 h with CM from young and old CM.
Data are mean  SEM of n = 3–4 mice per age group; > 200 cells were quantified per condition.
F Representative micrographs of neonatal fibroblasts and CMs treated with recombinant proteins: Tgfb2, Edn3 and Gdf15 for 48 h and immunostained against a-
SMA and EdU (fibroblasts) and a-actinin (CMs).
G–I Quantification of a-SMA- (G) and EdU-positive neonatal fibroblasts (H) and surface area (lm2) (I) in neonatal CMs following treatment with the indicated
recombinant proteins. Data are mean  SEM of n = 3–4 independent experiments.
Data information: Asterisks denote statistical significance with one-way ANOVA (multiple comparisons) (G, H, I) or two-tailed t-test (A, D, E). ***P < 0.001; **P < 0.01;
*P < 0.05. For all panels, scale bars represent 50 lm.
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AP treatment (Fig 7D). Additionally, we found that TAF in CMs
were significantly reduced (Fig 7E); however, we failed to detect
any differences in telomere FISH signals between INK-ATTAC mice
with or without clearance of p16Ink4a-positive cells (Fig EV5A).
Consistent with a role for CM senescence in age-dependent myocar-
dial remodelling, we found that AP treatment significantly reduced
the average cross-sectional area of CMs (Fig 7F), and decreased the
percentage area of fibrosis, without any change in heart function as
measured by % ejection fraction (Figs 7G and EV5B and C). Similar
results were observed in a model of cardiac hypertrophy induced by
thoracic irradiation. We found that TAF induced by thoracic irradia-
tion in INK-ATTAC mice were restored to the levels found in
sham-irradiated mice following AP treatment (Appendix Fig S6A–C).
Similarly, we found that thoracic irradiation resulted in CM hypertro-
phy and this was completely rescued by elimination of p16Ink4a-
positive cells (Appendix Fig S6D).
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Figure 6. Mitochondrial dysfunction is a feature of cardiomyocyte senescence and drives TAF in mouse cardiomyocytes in vivo.
A Mito and ETC genes with GSEA analysis: Clustered heatmap showing all genes associated with the “Mitochondrion” GO term in young and old, mouse CMs as
observed by the GSEA pre-ranked list enrichment analysis (normalised enrichment score: 1.70; FDR q-value < 0.05). Alongside this is a column clustered heatmap
displaying a list of genes from the electron transport chain (ETC) GO ontology. In both instances, genes are by column and samples by row with the colour
intensity representing column Z-score, where red indicates highly and blue lowly expressed.
B Real-time PCR gene expression analysis of MAO-A, MnSOD and catalase in isolated mouse CMs from young (3 months) and old (20 months) mice. Data are
mean  SEM of n = 4–5 per age group. Asterisks denote a statistical significance at P < 0.05 using two-tailed t-test.
C Mean % of 4-HNE- (top) or 8-oxodG-positive (bottom) CMs from 3 month (young) or 30 month (old) mice. Data are mean  SEM of n = 4 per age group. 100 CMs
were quantified per age group. Asterisks denote a statistical significance at P < 0.05 using two-tailed t-test.
D–G Mean % of TAF-positive nuclei (left graphs) or mean % of TAF (right graphs) in wild-type (control) compared to MAO-A transgenic mice with or without drinking
water supplemented with 1.5 g/kg/day NAC from the age of 4–24 weeks, MnSOD+/+ vs MnSOD/+, Catalase+/+ vs Catalase/, WT vs POLG double-mutant mice.
Data are mean  SEM of n = 3–4 per group. > 100 CMs were quantified per age group. Statistical analysis was performed using two-tailed t-test (E–G) or one-
way ANOVA (for multiple comparisons) (D); *P < 0.05.
H Scheme depicting isolated mouse adult CMs isolated from four animals were treated with or without 100 nM rotenone either in the presence of 5 mM NAC or
vehicle control (pre-treated for 30 min before rotenone treatment), for 24 h before fixation. Mean number of TAF (top graph) and mean % of TAF-positive nuclei
(bottom graph). Data are mean  SEM from four separate CM cultures isolated from 3-month-old mice. Fifty CMs were quantified per condition. Asterisks denote
a statistical significance at P < 0.05 using one-way ANOVA (Holm–Sidak method).
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Figure 7. Genetic clearance of p16-positive cells in aged mice reduces cardiomyocyte senescence, cardiac hypertrophy and fibrosis.
A Examples of individual short-axis cine-MR images of 3-month-old or 20-month-old mouse hearts. Ejection fraction and LV thickness were calculated based on
manual measurements of left ventricle epicardial and endocardial borders. % change in wall thickening calculation based on wall thickness at the four points
indicated. Measurements were made in all cine slices at end diastole and end systole. Graphs representing data obtained from MRI analysis of > 7 animals per age
group. Data are mean  SEM. Asterisks denote a statistical significance at P < 0.05 using Mann–Whitney U-test. Scale bars represent 5 mm.
B Comparison between mean number of TAF per CM and CM area in 22-month-old animals. Data are mean  SEM of n = 4. > 100 CMs were quantified per mouse.
Statistical analysis performed using one-way ANOVA (Holm–Sidak method); *P < 0.05.
C Scheme depicting experimental design for (D–F): 27-month-old INK-ATTAC mice were treated 4 times with AP20187 (or vehicle), 3 days in a row, every 2 weeks (2-
month-long treatment in total) and were sacrificed afterwards for analysis.
D Comparison between the % of p16- or eGFP-positive CMs by RNA in situ hybridisation per plane in INK-ATTAC mice (28–29 months old) treated with vehicle or
AP20187. Data are mean  SEM of n = 5 per age group. 100 CMs were analysed per mouse. Asterisks denote a statistical significance at *P < 0.05 or ***P < 0.001
using two-tailed t-test.
E Mean number of TAF (left graph) and mean % of TAF-positive nuclei (right graph) in CMs. Data are mean  SEM of n = 6 per age group. 100 CMs were analysed per
mouse. ***P < 0.001; **P < 0.01; *P < 0.05.
F Mean CM area lm2. Data are mean  SEM of n = 6 per age group, > 150 CMs analysed per mouse. Asterisks denote a statistical significance at *P < 0.05 using two-
tailed t-test.
G % of fibrotic area evaluated by Sirius Red staining. Data are mean  SEM of n = 6 per age group. Asterisks denote a statistical significance using Mann–Whitney test.
***P < 0.001.
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To investigate further the therapeutic impact of targeting senes-
cent cells to counteract cardiac ageing, we treated aged wild-type
mice with the previously described senolytic drug, ABT263 (navito-
clax; Zhu et al, 2016), or vehicle intermittently for 2 weeks
(Fig 8A). We found that navitoclax reduced telomere dysfunction in
cardiomyocytes without affecting telomere length (similar to what
was observed in aged INK-ATTAC mice following AP treatment;
Figs 8B and C, and EV5D). Consistent with its senolytic properties,
we found that navitoclax selectively killed senescent H9C2 CMs
in vitro (Fig EV5E and F).
Similarly, to genetic clearance of p16Ink4a cells in INK-ATTAC
mice, we found that navitoclax significantly reduced hypertrophy
and fibrosis in aged wild-type mice (Fig 8C and D). However, navi-
toclax had no significant impact on cardiac function, LV mass and
ventricle wall rigidity (Fig 8E–G). The decrease in mean CM size
without significant changes in LV mass suggested a compensatory
increase in overall CM number. Supporting de novo CM prolifera-
tion, we observed that frequency distribution analyses of CM cross-
sectional area suggested that the decrease in mean CM area follow-
ing navitoclax treatment is a function of both an elimination of the
largest CMs, presumably as these are senescent, and the appear-
ance of a “new” population of small CMs (Fig EV5G). This pheno-
type has previously been associated with CM regeneration (Waring
et al, 2014). To further investigate de novo CM regeneration follow-
ing navitoclax treatment, we injected EdU in 24-month-old mice for
7 days and quantified EdU-positive cells in combination with CM
markers TropC and PCM1 and cell membrane marker wheat germ
agglutinin (WGA). We found significantly more EdU-labelled CMs
in the navitoclax-treated animals than vehicle controls (0.23% vs
0.07%; Fig 8H–J). As CMs may undergo karyokinesis in the
absence of cytokinesis resulting in bi- or multi-nucleation, EdU
alone is not a marker of cell division. As such, we evaluated the
nucleation state of EdU-labelled CMs by analysing 3D images in 40-
lm-thick sections as previously described (Mollova et al, 2013).
Our data indicate senescent-cell clearance is accompanied by a
significant increase of both multi- and mono-nucleated CMs
(Fig 8H–J). Each image throughout the z-series was examined to
confirm nucleation state (Movies EV2 and EV3). However, < 25%
of all EdU incorporation resulted in multi-nucleated CMs. We next
evaluated the percentage of CMs positive for proliferation marker
Ki-67 and found a similar increase following navitoclax treatment
and in aged INK-ATTAC mice treated with AP (Figs EV5H and 8K).
Expression of Aurora B, a component of the contractile ring
required for cytoplasmic separation during cell division, was only
observed in CMs from hearts where senescent cells had been
cleared, where it was located in mid-body between nuclei, indica-
tive of cytokinesis (Hesse et al, 2018; Fig 8H). Altogether, our data
support that senescent CMs are involved in age-associated cardiac
hypertrophy and fibrosis and that their clearance may induce a
compensatory CM regeneration.
Discussion
During ageing and despite low level of proliferation, we observe
enrichment of DDR proteins at telomere regions, notoriously known
for their inefficient repair capacity, fuelled by the actions of telomere
binding proteins. TRF2 and its binding partner RAP1 have been
shown to prevent NHEJ-dependent telomeric DNA fusions by
inhibiting DNA-PK- and ligase IV-mediated end-joining (Bae &
Baumann, 2007). In contrast, homologous recombination can repair
telomere-induced DNA damage; however, this process is restricted
to proliferating cells undergoing S-phase and therefore not likely to
be relevant for post-mitotic CMs (Mao et al, 2016). As such, within
CMs, a cocktail of age-dependent mitochondrial dysfunction and
oxidative stress, coupled with limited CM turnover, fuels the occur-
rence of irreparable telomere-associated damage, which may insti-
gate a senescent-like phenotype (Appendix Fig S7).
While our data indicate that mitochondrial dysfunction and
ROS can induce CM senescence, it remains possible that the
observed age-dependent changes in mitochondrial gene expression
and morphology are a consequence of telomere dysfunction. In
mouse models of accelerated telomere shortening, critically short
telomeres have been shown to repress PGC1-a- and b-mediated
mitochondrial biogenesis (Sahin et al, 2011; Chang et al, 2016).
However, increased mitochondrial ROS driven by telomere
dysfunction has been shown to induce DNA damage and activate
a DDR in a positive feedback loop, making it experimentally
complex to unravel which is the initiating step in the process
(Passos et al, 2010).
There is still uncertainty regarding the physiological role of post-
mitotic CM senescence during the ageing process. Previously, stud-
ies have attributed the beneficial effects of clearance of senescent
cells in murine ageing heart to other proliferation-competent cells
and not CMs (Baker et al, 2016). Studies have also proposed a role
for telomere shortening in CM senescence: Short telomeres have
been observed in aged murine CMs (Rota et al, 2007) and in
cardiomyocytes from individuals with end-stage hypertrophic or
dilated cardiomyopathy (Chang et al, 2018) and mouse models of
accelerated telomere shortening exhibit cardiac dysfunction (Chang
et al, 2016). However, whether short telomeres per se are causal in
cardiomyocyte senescence during natural ageing has not been deter-
mined. Our data suggest that telomere length is not a limiting factor
in CM senescence since (i) genetic elimination of p16Ink4a-positive
cells or treatment with senolytic drug, navitoclax, in aged mice did
not affect telomere length or the frequency of very short telomeres
and (ii) since super-resolution STED microscopy, which improved
the resolution of clustered telomere signals, could not detect dif-
ferences in FISH intensity between telomeres co-localising or not
with cH2A.X. However, we acknowledge that there are limitations
to our experimental approach: While interphase telomere FISH
allows us to collect information regarding telomere length in speci-
fic cells of interest, it does not allow the recognition of telomeres in
specific chromosomes or the detection of telomere-free ends.
Furthermore, as we analyse 3-lm-thick tissue sections, we may not
capture the entirety of the cardiomyocyte nucleus. Finally, while
STED microscopy significantly improved resolution by threefold in
XY and nearly 2.3-fold in Z compared to standard confocal micro-
scopy, it is still possible that clusters of telomeres are not entirely
resolved using this method.
Key questions remain regarding the consequences of CM senes-
cence. While telomere dysfunction in CMs activates the classical
senescence-inducing pathways, p21CIP and p16Ink4a, CMs in
contrast to cardiac stromal cells do not produce a classical SASP.
Rather we have identified that factors such as Edn3, Tgfb2, and
Gdf15 are released by senescent CMs and promote myofibroblast
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activation and CM hypertrophy. Based on these data and the
observed reduction in myocardial remodelling following senescent-
cell elimination, we suggest that CM senescence and the SASP
contribute to age-related cardiac dysfunction clinically. As such,
they represent therapeutic targets to improve myocardial health in
the older population.
Another important question, which arises from this study, is
whether loss of senescent cardiomyocytes by senotherapies may
be detrimental for the heart, which may limit its clinical potential.
Our study, in accordance with others (Baker et al, 2016; Roos
et al, 2016; Demaria et al, 2017), shows that the loss of senescent
cardiomyocytes does not adversely alter cardiac function in aged
mice. Based on our observations, we would suggest that function
is maintained as a result of compensatory mechanisms that
include CM renewal and replacement, as indicated by the
increased frequency of EdU- and Ki-67-positive mononuclear CMs
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Figure 8. Pharmacological clearance of senescent cells with navitoclax (ABT 263) reduces cardiomyocyte senescence and stimulates cardiomyocyte
regeneration.
A Scheme depicting experimental design. Mice at 100 weeks (23 months) of age were treated with vehicle (Veh) or navitoclax (Nav) intermittently for 2 weeks. At
104 weeks, mice were injected every day with EdU for 1 week.
B Quantification of mean number of TAF and % of TAF-positive CMs in 24-month-old wild-type mice treated with vehicle or navitoclax (50 mg/kg/day). Data are
mean  SEM of n = 5–8 mice per group. More than 100 CMs were quantified per animal.
C CM cross-sectional area in 24-month-old wild-type mice treated with vehicle or navitoclax. Data are mean  SEM of n = 8 mice per group.
D (Left) Representative images of Sirius red staining and (right) % of fibrosis area in 24-month-old mice treated or not with navitoclax. Data are mean  SEM of
n = 3 per group. Scale bar represents 50 lm.
E–G MRI analysis of ejection fraction (EF%), left ventricle mass (LVmass) index and % of ventricle wall thickness (%WTC) in 24-month-old mice treated or not with
navitoclax. Data are mean  SEM of n = 6 mice per treatment group.
H Examples of confocal microscopy images of CMs positive for CM marker troponin-C (TropC), EdU, Ki-67, and Aurora B from navitoclax-treated animals. In the upper
right panel, white arrows identify two nuclei in the same CM that have incorporated EdU. In the lower right panel, white arrows identify EdU-expressing Aurora B
symmetrically between two nuclei. Scale bars represent 20 lm.
I Table summarising numbers of CMs quantified in (J).
J Quantification of EdU-positive CMs (mono- or multi-nucleated) in vehicle- and navitoclax-treated animals. Data are mean  SEM of n = 5–6 mice per group.
K % of Ki-67-positive CMs in 29-month-old INK-ATTAC mice treated with vehicle or AP20187. Data are mean  SEM of n = 4–6 mice per group.
Data information: Asterisks denote a statistical significance using two-tailed t-test (B, C, K) or Mann–Whitney test (D, J). ***P < 0.001; **P < 0.01; *P < 0.05.
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and the observation of CMs expressing Aurora B symmetrically
between nuclei (Hesse et al, 2018). Following senescence clear-
ance, we also identified an increase in CM karyokinesis. A process
that can be associated the CM hypertrophy that occurs during
adaptive and ultimately maladaptive remodelling in response to
pathological conditions which involve CM loss, including myocar-
dial infarction and pressure overload (Ahuja et al, 2007). While
the observed global reduction in hypertrophy argues against
karyokinesis and hypertrophy being the main compensatory mech-
anisms following senescent CM elimination, extended longitudinal
studies of cardiac function will need to be conducted to ascertain
whether maladaptive remodelling and cardiac dysfunction occur
in the longer term.
In summary, our study provides evidence for the concept that
post-mitotic CM senescence is a major effector of myocardial ageing
and offers a proof-of-principle that modulation of cardiac senes-
cence is a viable treatment strategy. While described in myocytes,
we speculate that our proposed mechanism may explain PoMiCS
which has been detected in other tissues such as neurones (Jurk
et al, 2012), osteocytes (Farr et al, 2017), and adipocytes
(Minamino et al, 2009).
Materials and Methods
Animals and procedures
Ageing studies
Mixed-sex C57BL/6 mice were analysed at either 3, 15, 20, 24 or
30 months of age. For whole-body X-ray irradiation, mixed-sex
1-month-old C57BL/6 mice were irradiated with 2 Gy followed by
11-month recovery period before culling. TERC/ C57BL/6 mice.
Male mice were bred to produce successive generations of mice with
decreasing telomere length. Hearts from fourth-generation (G4)
mixed-sex mice were studied. Catalase/ and MnSOD+/ mice.
Mouse models for elevated reactive oxygen species and mitochon-
drial dysfunction: Catalase/ and MnSOD+/ were aged until 22–
24 months. PolgAmut/mut mice. Mice with a knock-in missense muta-
tion (D257A) at the second endonuclease-proofreading domain of
the catalytic subunit of the mitochondrial DNA (mtDNA) poly-
merase Polc (PolgAmut/mut mice) and PolgA+/+ mice were used at
12 months of age. Mice were group-housed in individually venti-
lated cages with a constant temperature of 25°C, a 12-h light/dark
cycle and with RM3 expanded chow (Special Diet Services).
For the above mice projects were approved Newcastle University
Animal Welfare Ethical Review Board and experiments were
conducted in compliance with the UK Home Office (PPL P3FC7C606
or 60/3864).
MAO-A transgenic mice
MAO-A mice, on the C57BL6/J background, with cardiac-specific
overexpression of MAO-A driven by the a-MHC promoter are previ-
ously described (Villeneuve et al, 2013). Mixed-sex MAO-A
offspring and non-transgenic littermates were used for the experi-
ments at 6 months of age. N-acetyl-cysteine was provided at 1.5 g/
kg/day between 1 and 6 months of age. Mice were housed in a
pathogen-free facility (B 31 555 010). Experiments were approved
by University of Toulouse local ethic committee (CEEA-122
2015-01) and conformed to the Guide for the Care and Use of Labo-
ratory Animals published by the Directive 2010/63/EU of the Euro-
pean Parliament.
INK-ATTAC mouse model for the clearance of senescent cells
Experimental strategy for making transgenic mice with a senescence-
activated promoter coupled to the drug-activatable ATTAC “suicide”
transgene and GFP was devised by JLK and TT. INK-ATTAC mice
were created and characterised at Mayo through a collaboration
among the JLK-TT, NKL and van Deursen laboratories. Animals
were crossed onto a C57BL/6 background (van Deursen laboratory)
and bred, genotyped and aged (JLK-TT laboratory). Mixed-sex mice
were housed in a pathogen-free facility, at 2–5 mice/cage with 12-h
light/12-h dark cycle at 24°C and ad libitum access to standard
mouse diet (Lab Diet 5053, St Louis, MO, USA) and water. AP20187
(10 mg/kg) or vehicle was administered to 27-month-old mice by
intraperitoneal injection every 3 days for 2 months.
Senolytic treatment of male C57BL/6 mice
Mice at 22 months of age were purchased from Charles River
(Charles River Laboratories International, UK). Mice were randomly
assigned to a treatment group. ABT263 (navitoclax) or vehicle alone
was administered to mice by oral gavage at 50 mg/kg body weight
per day (mg/kg/day) for 7 days per cycle for two cycles with a
1-week interval between the cycles. Hearts were collected directly
into 50 mM KCl to arrest in diastole.
For all animal studies, details of sample sizes are included in the
figure legends.
Human tissue collection and ethics
Human heart tissue was obtained from male and female patients
undergoing open-heart surgery for aortic stenosis, with a section of
the right atrial appendage being placed in 10% neutral buffered
formalin (VWR, 9713.9010) immediately after dissection. Subse-
quent processing steps for paraffin embedding were the same as for
mouse tissue (as described below). All tissue samples were obtained
under the clause in the Human Tissue Act that enables anonymised
samples to be taken without consent in the context of an ethically
approved study. This study was approved by the Research Ethics
Committee, UK, REC reference number: 10/H0908/56.
Adult mouse cardiomyocyte isolation and purification
Hearts from mixed-sex CJ57/BL6 mice were placed on a Langendorff
setup. Cell suspensions were obtained by enzymatic digestion and
sedimentation. To enrich the CM population, cells were stained at
4°C for 30 min with a cocktail of biotin-conjugated antibodies
(CD31 (390), CD45 (30-F11), and Sca-1 (D7); BioLegend) and the
EasySepTM Mouse Biotin Positive Selection Kit, used to remove the
labelled non-CM cells. Cultured CM purity was assessed by
immunofluorescent staining against CD31, Sca-1, CD45, and a-
actinin. Qiagen RNA extraction kit was used of RNA isolation. CMs
were cultured on laminin-coated wells in MEM with Hank’s salts
and L-glutamine (SIGMA), 0.1 mg/ml BSA, 10 mM butanedione
monoxime, ITS Liquid Media Supplement (SIGMA).
Culture of H9C2 rat myoblasts
H9C2 rat heart-derived embryonic myocytes (ATCC) were cultured
in DMEM (SIGMA), 5% foetal calf serum, penicillin/streptomycin
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100 U/ml, 2 mM glutamine, at atmospheric conditions (air plus 5%
CO2).
Neonatal rat ventricular myocyte (NRVM) isolation
For neonatal cardiomyocytes, hearts of mixed-sex 2- to 3-day-old
Sprague Dawley rats were dissociated with 0.43 mg/ml collagenase
type A (Roche) and 0.5 mg/ml pancreatin (Sigma). Myocyte enrich-
ment was performed by centrifugation through a discontinuous Percoll
gradient, and the resultant suspension of myocytes was plated onto
gelatin-coated culture dishes in mix medium containing 80% DMEM
High Glucose and 20% M199, supplemented with 10% FBS, 5% HS
and 1% antibiotics. After plating, cells were cultivated in mix medium
with reduced FBS concentration (5%). Plasmid transfections were
performed using Lipofectamine 2000 reagent (Life Technologies).
Mouse embryonic cardiomyocyte isolation and culture
Under sterile conditions, hearts were removed from mixed-sex
E17.5 embryos and then cut into multiple fragments in cardiomy-
ocyte balanced salt buffer (CBSB; 116 mM NaCl, 20 mM HEPES,
1 mM NaH2PO4, 5.365 mM KCl, 831 nM MgSO4). Heart fragments
were then incubated in CBSB with 80 U/ml collagenase type II
(Worthington) for 5 min. Allowing fragments to settle, supernatant
was removed and centrifuged at 700 × g for 5 min. Remaining frag-
ments were then re-suspended in cardiomyocyte enzyme solution
(CBSB, 80 U/ml collagenase II and 0.25 mg/ml trypsin) for 30 min,
with gentle shaking. Fragments were allowed to settle, and then,
supernatant containing dissociated cells was removed and centri-
fuged at 700 × g for 5 min, washed in FBS and stored at 4°C.
Remaining fragments were then re-suspended as before into
cardiomyocyte enzyme solution. After centrifugation, the super-
natant was discarded and pellet was again re-suspended in 4°C FBS
and placed on ice. Re-suspension, centrifugation and collection were
then repeated until all fragments had been dissolved (7–10 cycles).
All FBS suspensions were pooled together and centrifuged at
700 × g for 5 min. The supernatant was then discarded and cells re-
suspended in cardiomyocyte growth medium (Dulbecco’s Modified
Eagle’s Medium (DMEM), supplemented with 17% Medium 199,
5% FBS, 10% horse serum (SIGMA, H0146), 100 lg/ml strepto-
mycin, 100 units/ml penicillin and 2 mM L-glutamine). Cells were
then seeded into a collagen-coated (1 mg/ml) T75 culture flask
(SIGMA) and incubated at 37°C for 2 h. After the incubation, the
supernatant, containing cardiomyocytes, was collected from the
flask and the adherent fibroblasts discarded. Cardiomyocytes were
then cultured in Cardiomyocyte Growth Medium.
Culture and differentiation of AC10 cells
Cells were seeded at a density of 2.5 × 104/ml on glass coverslips
coated with 12.5 lg/ml fibronectin in 0.02% gelatin in DMEM/F-12
with 12.5% FBS. Once confluent, medium was then replaced by mito-
gen-deficient medium, DMEM/F-12 supplemented with 2% HS and
insulin–selenium–transferrin supplement (ITS, Invitrogen), and the
cells cultured for a further 2 weeks to allow terminal differentiation.
Cell culture, transfections and treatments
Transfection of H9C2 myoblasts and rat neonatal cardiomyocytes
Cells were transiently transfected with a 53BP1-GFP reporter protein
using the plasmid pG-AcGFP-53BP1c or either TRF1-FokI-D450A or
TRF1-FokI or pBABe-HA-ER-IPpoI plasmids using Lipofectamine
2000 (ThermoFisher) at a ratio of 3 ll Lipofectamine 2000 to 1 lg
DNA following the manufacturer’s protocol. Transfected cells
detected with an anti-FLAG antibody (SIGMA).
Stress-induced senescence of cultured cells
For H9C2 cells, rat neonatal or mouse embryonic CM senescence
was induced by 10 Gy X-ray irradiation. In both cell types, we
observed senescence after 10 days using SA-b-Gal assay (> 70%
positive cells) and absence of proliferation marker Ki-67. H9C2
senescent or proliferating cells were treated with ABT-263 (Navito-
clax; AdooQ Bioscience, USA), and viability was assessed using a
Tali Image-Based Cytometer (Invitrogen).
EdU incorporation assays
Cells were incubated in 10 lM EdU in normal growth medium for
24 h. EdU was detected using the Click-iT EdU Imaging Kit (Invit-
rogen), as per manufacturer’s protocol.
Thoracic Irradiation
A TrueBeam linear accelerator (Varian Medical Systems, Palo Alto)
was used for the mouse studies. Anesthetised INK-ATTAC mice
(2 months of age) received a single, 20 Gy radiation dose delivered
to the thoracic region. The radiation beam was collimated to an area
encompassing the mouse lungs and the radiation field positions on
the mice were verified using kV-CBCT and 2D kV imaging of the
animals prior to irradiation. The dose rate at the prescription point
was 14.8 Gy/min, using 89 cm source to the surface distance. Dose
was prescribed to midline in the mice and was confirmed using film
and ion chamber dosimetry. All mice prophylactically received
100 mg/ml Baytril antibiotic in their drinking water for 3 weeks
post-irradiation. One month following irradiation, mice were rando-
mised to AP20187 (10 mg/kg), delivered by intraperitoneal injection
(treatments twice weekly) or vehicle groups. Body weight was
monitored weekly. Mice were euthanised 6 months post-irradiation
exposure using a lethal dose of pentobarbital. Animal experiments
involving INK-ATTAC mice were performed under protocols
approved by the Mayo Clinic Institutional Animal Care and Use
Committee.
Live-cell imaging
For live-cell time-lapse microscopy of 53BP1 reporter fluorescence,
H9C2 cells were plated on glass coverslip-bottomed dishes
(MatTek), and cells were imaged every 10 min for 10 h as Z-stacks
over 7 lm with a 63× objective (NA = 1.4), using a Zeiss spinning
disc confocal microscope with cells incubated at 37°C with humidi-
fied 5% CO2. AcGFP-53BP1 foci dynamics were analysed using
Imaris Software.
Immunohistochemistry
Deparaffinisation, hydration and antigen retrieval of formalin-fixed
paraffin-embedded heart tissues were performed as previously
described. Sections were incubated with M.O.M mouse IgG blocking
reagent (90 ll blocking reagent: 2.5 ml TTBS) for 1 h at room
temperature. After 2 × 5 minute PBS washes, sections were incu-
bated with avidin for 15 min, rinsed with PBS, and then incubated
with biotin for 15 min at room temperature. Primary antibody was
then diluted in M.O.M diluents (7,500 ml TTBS: 600 ll protein
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concentrate) and incubated overnight at 4°C. After 2 × 5 min PBS
washes, sections were incubated in biotinylated-mouse IgG reagent
diluted in blocking solution (1:200) for 30 min at room temperature.
After 2 × 5 min PBS washes, endogenous peroxidase activity was
blocked by incubating sections in 0.9% H2O2 in water for 30 min.
After 2 × 5 min PBS washes, sections were incubated in AB
complex for 30 min at room temperature. After 3 × 5 min PBS
washes, sections were then incubated in NovaRed solution for up to
10 min, rinsed with water, counterstained with haematoxylin for
2 min, washed in PBS and then transferred to ammonia water for
30 s. After a 1-min wash in water, sections were then dehydrated
through 70, 90 and 100% ethanol and then histoclear for 5 min
each. Sections were then mounted with DPX.
Primary antibodies used were as follows: mouse monoclonal
anti-4HNE (1:100, MHN; JaICA), mouse monoclonal anti-8-OHdG
(1:100, MOG; JaICA) and rabbit polyclonal anti-p21 (1:200, ab7960;
Abcam).
Immunofluorescence
Cells were grown on sterile coverslips, fixed with 2% PFA and
permeabilised with PBG-T (PBS, 0.4% fish-skin gelatin, 0.5% BSA,
0.5% Triton X-100). Cells were incubated in primary antibody for
1 h at room temperature (RT), followed by incubation in secondary
antibody for 45 min. Primary antibodies: anti-c-H2AX (1:200,
#9718; Cell Signaling), anti-53BP1 (1:200, #4937; Cell Signaling),
anti-53bp1 (1:200, nb100-305, Novus Biologicals), anti-a-actinin
(1:100, A7811; SIGMA), anti-troponin I (1:200, Catalogue,
Company), anti-troponin-C (1:200, Abcam ab30807), anti-PCM1
(1:200, ab154142; Abcam), anti-FLAG (1:1,000, F1804; SIGMA) and
anti-Ki-67 (1:250 (4 lg/ml), ab15580; Abcam). Secondary antibod-
ies: Alexa Fluor 488, Alexa Fluor 594 or Alexa Fluor 647 (Invit-
rogen).
Microscopy
For fluorescence microscopy, a Leica DM5500B wide-field fluores-
cence microscope and Zeiss AxioObserver Spinning Disk confocal
microscope were used. For super-resolution STED microscopy, a
Leica SP8 confocal (inverted) gSTED 3D super-resolution micro-
scope was used. For all quantitative immunohistological analysis
studies were performed in a blinded manner.
Immuno-FISH and FISH
Immuno-FISH was performed as described in Hewitt et al (2012).
Briefly, cells were grown on coverslips and immunocytochemistry
performed as described above, with either anti-cH2AX (1:200, 9718;
Cell Signaling) or anti-53BP1 (1:200, 4937; Cell Signaling). Cells were
then fixed with methanol: acetic acid (3:1), dehydrated through an
alcohol series, air-dried and incubated with PNA hybridisation mix
[70% deionised formamide (SIGMA), 25 mM MgCl2, 1 M Tris pH
7.2, 5% blocking reagent (Roche) containing 2.5 lg/ml Cy3-labelled
telomere-specific (CCCTAA) peptide nucleic acid probe (Panagene)],
for 10 min at 80°C in a then for 2 h at RT in the dark humidifier
chamber. Cells were washed with 70% formamide in 2× SSC for
10 min, 2× SSC for 10 min and PBS for 10 min. Cells were mounted
with ProLong Gold Antifade Mountant with DAPI (ThermoFisher).
For immuno-FISH in formalin-fixed paraffin-embedded tissues,
sections were de-waxed and rehydrated through an alcohol series.
Antigen retrieval was via 0.1 M citrate buffer boiling. Sections were
incubated in blocked buffer (1:60 Normal Goat Serum in PBS/0.1%
BSA) followed by primary antibody at 4°C. Sections were then incu-
bated with a biotinylated secondary antibody (1:200) followed by
avidin-DCS (1:500). Sections were post-fixed in 4% PFA for 20 min,
and FISH was carried out as described above. For centromere-FISH
(SADS detection), a FAM-labelled, CENPB-specific (centromere;
ATTCGTTGGAAACGGGA) peptide nucleic acid probe (Panagene)
was used. Frequency of SADS was assessed by quantification of
decondensed/elongated centromeres.
RNA in situ hybridisation
RNA-ISH was performed after RNAscope protocol from Advanced
Cell Diagnostics, Inc. (ACD). Paraffin sections were deparaffinised
with Histoclear, rehydrated in graded ethanol (EtOH), and H2O2 was
applied for 10 min at RT followed by two washes in H2O. Sections
were placed in hot retrieval reagent and heated for 30 min. After
washes in H2O and 100% EtOH, sections were air-dried. Sections
were treated with protease plus for 30 min at 40°C, washed with
H2O and incubated with target probe (p16, eGFP) for 2 h at 40°C.
Afterwards, slides were washed with H2O followed by incubation
with AMP1 (30 min at 40°C) and next washed with wash buffer
(WB) and AMP2 (15 min at 40°C), WB and AMP3 (30 min at 40°C),
WB and AMP4 (15 min at 40°C), WB and AMP5 (30 min at RT) and
WB and, finally, AMP6 (15 min at RT). Finally, RNAscope 2.5 HD
Reagent kit-RED was used for chromogenic labelling. After counter-
staining with haematoxylin, sections were mounted and cover-
slipped. All analysis was performed in a blinded manner.
Crosslinked chromatin immunoprecipitation assay (ChIP)
Three-month-old and 30-month-old frozen heart tissues (n = 3 per
age group) were powdered using dry pulverisation cryoPREP
(Covaris). The powder was then re-suspended into 1% formalde-
hyde solution in PBS and cells cross-linked for 5 min at RT, then
quenched with glycine buffer at final concentration of 125 mM. The
cells were rinsed in cold PBS and harvested into PBS with protease
inhibitors and centrifuged for 5 min, 4°C, 1,000 × g. The pellet was
re-suspended in ChIP lysis buffer (1% SDS, 10 mM EDTA, 50 mM
Tris–HCl pH 8.1) and incubated for 20 min on ice. Lysate was soni-
cated to generate average size fragment of 200–700 bp; cell debris
was pelleted by centrifugation for 10 min, 4°C, 8,000 × g. The
supernatant contained chromatin, which was quantified using
OD260 on Nanodrop.
Twenty-five micrograms of chromatin per IP was diluted 1:10
with dilution buffer (1.1% Triton, 1.2 mM EDTA, 16.7 mM Tris–
HCl pH 8.1, 167 mM NaCl, with protease inhibitors) and
precleared by incubating with 25 ll blocked Staph A membranes
(Isorbin) for 15 min. Precleared chromatin was then incubated
with 5 lg anti-cH2AX (phospho S139; Abcam, ab2893) and
species- and isotype-matched control ChIP grade IgG (Abcam,
ab46540) overnight at 4°C. Immunoprecipitated chromatin was
collected with blocked Staph A membranes, which were then
sequentially washed with cold buffers; Low Salt Wash Buffer
(0.1% SDS, 1% Triton X-100, 2 mM EDTA, 20 mM Tris–HCl pH
8.0, 150 mM NaCl), High Salt Wash Buffer (0.1% SDS, 1% Triton
X-100, 2 mM EDTA, 20 mM Tris–HCl pH 8.0, 500 mM NaCl), LiCl
Wash Buffer (0.25 M LiCl, 1% NP-40, 1% sodium deoxycholate,
1 mM EDTA, 10 mM Tris–HCl pH 8.0) and two washes in TE Buf-
fer (10 mM Tris pH 8.0, 1 mM EDTA). The immunoprecipitated
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chromatin was eluted in 500 ll Elution buffer (1% SDS, 100 mM
NaHCO3), cross-links reversed and DNA obtained by phenol:chlo-
roform extraction and gel purification. Real-time PCR specific for
telomeric repeats was performed as described in Hewitt et al
(2012). Briefly, 4 ll of ChIP eluate (bound fraction) was added to
a final volume of 13 ll quantitative PCR containing 6.5 ll Jump-
start SYBR master mix (Sigma) and 10 pmol primer mix. Telomere
PCR conditions were as follows: 10 s at 95°C followed by 40
cycles of 10 s at 95°C, 30 s at 55°C, and 30 s at 72°C followed by
ABI7500 Fast Real-Time PCR System machine predetermined melt
curve analysis (Applied Biosystems). Total input fraction was also
collected from chromatin samples. Bound to input (B/I) ratios
were determined for each amplicon by taking a 4 ll aliquot of the
DNA extracted from the input and bound samples. These were
amplified together with a defined amount of genomic DNA on the
same plate, using the latter to construct the standard curve.
Isotype-matched irrelevant antibody control (IgG) value was
subtracted from the result before plotting the graph. Each PCR
was performed in triplicate and results calculated using the follow-
ing equation: (1/(2A)) × 100.
Senescence-associated b-galactosidase activity assay
SA-b-Gal activity assay was performed as described previously
(Dimri et al, 1995). For in vitro studies, cells were grown on sterile
coverslips, and for in vivo studies, samples were cryo-embedded
and staining performed on 10 lm sections. Samples were fixed with
2% paraformaldehyde in PBS for 5 min, washed with PBS for 5 min
and then incubated at 37°C overnight in SA-b-Gal solution contain-
ing 150 mM sodium chloride, 2 mM magnesium chloride, 40 mM
citric acid, 12 mM sodium phosphate dibasic, 5 mM potassium
ferricyanide, 5 mM potassium ferrocyanide and 1 mg/ml 5-bromo-
4-chloro-3-indolyl-b-d-galactosidase (X-Gal) at pH 5.5. For in vivo
staining and quantifications, sections were co-labelled with anti-
troponin-C and WGA as above. All analysis was performed in a
blinded manner.
TRAP assay
Heart samples were snap-frozen in liquid nitrogen immediately after
dissection. Using a liquid nitrogen-cooled pestle and mortar, tissues
were ground into a fine powder. Telomerase activity was then deter-
mined following the TeloTAGGG Telomerase PCR ELISA kit (Roche).
Assessment of cardiomyocyte hypertrophy
Hypertrophy was assessed by cross-sectional area using established
methods as described (Shenje et al, 2014). Troponin-C was used to
identify CMs and membranes labelled with wheat germ agglutinin
(WGA; Alexa Fluor 647, W32466, Invitrogen). Only CMs in the left
ventricle free wall were analysed. To control for tissue orientation
only myocytes that were surrounded by capillaries, all displaying a
cross-sectional orientation were analysed. All analysis was
performed in a blinded manner.
Evaluation of cardiomyogenesis in mice
To allow retrospective quantification of cumulative proliferation
and binucleation, occurring the week following navitoclax treat-
ment, mice were injected (intraperitoneal) with EdU (100 lg/g body
weight) once daily every 24 h for seven consecutive days (Fig 7A).
More than five animals were studied for each treatment group. EdU
incorporation was detected using the Click-iTTM EdU Imaging Kit
(ThermoFisher). Sections were also labelled with primary antibody
for troponin-C and the membrane-specific label WGA. A Leica SP5
laser scanning confocal system was used for the analysis. Analysis
was carried out in a blinded fashion similar to our previous studies
(Richardson et al, 2015). In brief, myocardial tissue was sectioned
transversely in 40 lM sections, with sections separated by intervals
of 200 lM, allowing representative analysis throughout the ventri-
cle. Over 80 images were taken, in a random fashion, spanning over
eight individual sections per heart. Analysis included the assessment
of EdU labelling in > 1,500 cardiomyocytes per heart. Incorporation
of EdU in the cardiomyocyte population was quantified based on
the detection of EdU labelling in the nucleus of a troponin-C-expres-
sing cell. To discriminate proliferation from binucleation (karyokine-
sis without cytokinesis), the number of EdU-labelled nuclei within
each Edu+ cardiomyocyte was assessed using WGA to identify the
cell membrane. The incorporation of EdU into a cell with only one
nucleus was considered to be a result of proliferation, when two or
more EdU-labelled nuclei were found in the same cardiomyocyte, this
was considered to have been incorporated during a multi-nucleation
event. Ki-67 or Aurora B-expressing cardiomyocytes were identified
as co-expression of Ki-67/Aurora B and troponin-C within a single-
cell membrane (based on WGA labelling). The total percentage of
positively expressing cardiomyocytes was calculated as previously
described (Richardson et al, 2015), based on the analysis of > 4,000
cardiomyocytes per heart. All quantifications were performed blinded
using digital image analysis (ImageJ; U.S. National Institutes of
Health; http://rsbweb.nih.gov/ij/).
MR imaging and analysis
Magnetic resonance images were acquired with a horizontal bore
7.0T Varian microimaging system (Varian Inc., Palo Alto, CA, USA)
equipped with a 12-cm microimaging gradient insert (40 gauss/cm)
and analysed as described previously (Redgrave et al, 2017).
Percentage change in wall thickening was calculated from the mean
of wall thickness at four points in all slices at end systole and end
diastole thickness. % change = (EST  EDT)/EDT × 100. All analy-
sis was performed in a blinded manner.
RNA sequencing
Paired-end reads were aligned to the mouse genome (mm9) using a
splicing-aware aligner (tophat2). Only unique reads were retained.
Reference splice junctions were provided by a reference transcrip-
tome (Ensembl build 67), and novel splicing junctions determined
by detecting reads that spanned exons that were not in the reference
annotation. True read abundance at each transcript isoform was
assessed using HTSeq (Python) before determining differential
expression with the tool DESeq2, which models mean-variance
dependence within the sample set. Significance was determined
using an FDR-corrected P-value ≤ 0.05.
Computational modelling
Two different models were constructed to examine different hypothe-
ses on how TAF accumulate in cells. The models were encoded in the
Systems Biology Markup Language (SBML) modelling standard
(Hucka et al, 2003) with the Python SBML shorthand tool
(Wilkinson, 2011). Model simulations were carried out in COPASI
(Hoops et al, 2006), and the results were analysed and plotted in R
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using ggplot2 (Wickham, 2009). We used stochastic simulation (Gille-
spie direct method) in order to be able to account for the variability
in the experimental data. The models were deposited in BioModels
(Chelliah et al, 2015) and assigned the identifiers MODEL1608250000
and MODEL1608250001.
Cufflinks FPKM determination
To calculate library normalised read counts for each transcript in
every replicate, we used the tool Cufflinks, which returns the propor-
tion of reads per million, which mapped to each gene isoform.
Gene set enrichment analysis (GSEA)
We perform a GSEA by creating a ranked list of the DESeq2 results
file, where genes are ranked by their log-transformed, non-FDR-
corrected P-values. This list is then used as an input to the GSEA
software, which assesses positive or negative shifts of GO ontology
classes in the global distribution of gene expression. This is
achieved by the calculation of an enrichment score, which reflects
the movement of a particular ontological class to the positive and
negative extremes of the distribution of the expression of all genes.
Permutation testing then allows for the estimation of significance
prior to FDR correction.
Heatmaps
Heatmaps were created in R using the ggplots package. These heat-
maps displaying normalised (row scaled—Z-score) FPKM gene
expression across a series of replicates were clustered using a Pear-
son correlative clustering approach in the “hclust” R package.
Principal component analysis
Principal component analysis was performed in R using the prcomp
method.
Statistical analysis
We conducted two-tailed t-tests, one-way ANOVA, Gehan–Breslow
and Mann–Whitney tests using GraphPad Prism.
Data accessibility
The RNA-seq data from this publication have been submitted to the
GEO database (http://www.ncbi.nlm.nih.gov/geo/), accession
number: GSE95822. The models were deposited in BioModels and
assigned the identifiers MODEL1608250000 and MODEL1608250001
(https://www.ebi.ac.uk/biomodels-main/).
Expanded View for this article is available online.
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